日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical and Genomic Features and Prognostic Biomarkers of Oligometastatic Nonsmall Cell Lung Cancer

寡转移性非小细胞肺癌的临床和基因组特征及预后生物标志物

Deek, Rebecca A; Kim, Jongmyung; Kumar, Ritesh; Medina, Benjamin; Langenfeld, John; Kontopidis, Ioannis; Lazzaro, Richard; Nie, Ke; Hathout, Lara; Guler, Ozan; Onal, Cem; Patel, Eshan; Haigentz, Missak; Jabbour, Salma K; Deek, Matthew P

HIV Associated Lung Cancer: Unique Clinicopathologic Features and Immune Biomarkers Impacting Lung Cancer Screening and Management

HIV相关肺癌:独特的临床病理特征和影响肺癌筛查和管理的免疫生物标志物

Cali Daylan, Ayse Ece; Maia, Catarina Martins; Attarian, Shirin; Guo, Xiaoling; Ginsberg, Mindy; Castellucci, Enrico; Gucalp, Rasim; Haigentz, Missak; Halmos, Balazs; Cheng, Haiying

Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus-Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

MEDI0457联合度伐利尤单抗治疗人乳头瘤病毒相关复发/转移性头颈部鳞状细胞癌患者的安全性和有效性

Aggarwal, Charu; Saba, Nabil F; Algazi, Alain; Sukari, Ammar; Seiwert, Tanguy Y; Haigentz, Missak; Porosnicu, Mercedes; Bonomi, Marcelo; Boyer, Jean; Esser, Mark T; Cheng, Lily I; Agrawal, Sonia; Jennings, Emily C; Durham, Nicholas M; Fraser, Karl; Lissa, Delphine; Gong, Maozhen; Ceaicovscaia, Natalia; Gascó Hernández, Amaya; Kumar, Rakesh

Phase I Trial of the Multi-kinase Inhibitor Cabozantinib, a CYP3A4 Substrate, plus CYP3A4-Interacting Antiretroviral Therapy in People Living with HIV and Cancer (AMC-087)

多激酶抑制剂卡博替尼(CYP3A4 底物)联合 CYP3A4 相互作用抗逆转录病毒疗法治疗 HIV 合并癌症患者的 I 期试验 (AMC-087)

Haigentz, Missak Jr; Lee, Jeannette Y; Chiao, Elizabeth Y; Aboulafia, David M; Ratner, Lee; Ambinder, Richard F; Baiocchi, Robert A; Mitsuyasu, Ronald T; Wachsman, William; Sparano, Joseph A; Rudek, Michelle A

Safety and Tolerability of Carboplatin and Paclitaxel in Cancer Patients with HIV (AMC-078), an AIDS Malignancy Consortium (AMC) Study

卡铂和紫杉醇在 HIV 合并癌症患者中的安全性和耐受性 (AMC-078),一项艾滋病恶性肿瘤联盟 (AMC) 研究

Haigentz, Missak; Moore, Page; Bimali, Milan; Cooley, Timothy; Sparano, Joseph; Rudek, Michelle; Ratner, Lee; Henry, David; Ramos, Juan; Deeken, John; Rubinstein, Paul; Chiao, Elizabeth

Tracheostomy during SARS-CoV-2 pandemic: Recommendations from the New York Head and Neck Society

SARS-CoV-2 大流行期间的气管切开术:纽约头颈学会的建议

Miles, Brett A; Schiff, Bradley; Ganly, Ian; Ow, Thomas; Cohen, Erik; Genden, Eric; Culliney, Bruce; Mehrotra, Bhoomi; Savona, Steven; Wong, Richard J; Haigentz, Missak; Caruana, Salvatore; Givi, Babak; Patel, Kepal; Hu, Kenneth

Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer

一项针对复发或转移性头颈癌患者的化疗联合或不联合贝伐单抗的III期随机试验

Argiris, Athanassios; Li, Shuli; Savvides, Panayiotis; Ohr, James P; Gilbert, Jill; Levine, Marshall A; Chakravarti, Arnab; Haigentz, Missak Jr; Saba, Nabil F; Ikpeazu, Chukwuemeka V; Schneider, Charles J; Pinto, Harlan A; Forastiere, Arlene A; Burtness, Barbara

Targeting the EGFR and Immune Pathways in Squamous Cell Carcinoma of the Head and Neck (SCCHN): Forging a New Alliance

靶向头颈部鳞状细胞癌(SCCHN)中的EGFR和免疫通路:建立新的联盟

Saba, Nabil F; Chen, Zhuo Gerogia; Haigentz, Missak; Bossi, Paolo; Rinaldo, Alessandra; Rodrigo, Juan P; Mäkitie, Antti A; Takes, Robert P; Strojan, Primoz; Vermorken, Jan B; Ferlito, Alfio

The Current Role of Salvage Surgery in Recurrent Head and Neck Squamous Cell Carcinoma

挽救性手术在复发性头颈部鳞状细胞癌中的当前作用

Hamoir, Marc; Schmitz, Sandra; Suarez, Carlos; Strojan, Primoz; Hutcheson, Kate A; Rodrigo, Juan P; Mendenhall, William M; Simo, Ricard; Saba, Nabil F; D'Cruz, Anil K; Haigentz, Missak Jr; Bradford, Carol R; Genden, Eric M; Rinaldo, Alessandra; Ferlito, Alfio

AHNS Series: Do you know your guidelines? Principles of treatment for locally advanced or unresectable head and neck squamous cell carcinoma

AHNS系列:您了解您的指南吗?局部晚期或无法切除的头颈部鳞状细胞癌的治疗原则

Fulcher, Cory D; Haigentz, Missak Jr; Ow, Thomas J